Between the climate crisis and global pandemics, we’re living in remarkably fraught times. Undaunted by the magnitude of the challenges, Silicon Valley has been hard at work seeking to mitigate the
Its technology is a way to grow and control cells without the need for any of those expensive recombinant proteins for cell production.
I tell you what, folks. The roundtable discussions at TechCrunch Disrupt — coming to you live and in person on October 18-20 in San Francisco — will be off the hook. Disrupt attendees love roundta
Smaller seed rounds mean shorter runways, so partnering with an investor who actually understands your business well enough to add value is critical.
Hello friends and welcome to Daily Crunch, bringing you the most important startup, tech and venture capital news in a single package.
With a focus on education that addresses the fragmentation associated with infertility care, Kindbody is growing at a remarkable pace, but it's also helping many patients feel seen and heard for the f
Hello friends and welcome to Daily Crunch, bringing you the most important startup, tech and venture capital news in a single package.
"It's important as an investor to be extremely humble, because we're going to be wrong a lot. I have this phrase that I use all the time: knowledge competes with imagination."
Has it ever been your responsibility to tell someone else that their job has been eliminated? I have, and it's one of the most difficult things I've ever done at work.
To learn more about where top VCs are searching for opportunities, and solicit their advice for entrepreneurs who want to attract attention, I asked four investors to share their thoughts.
Two weeks ago, 50 founders and investors shared their insights on how the world can tackle the planetary "Code Red" with over 2,000 participants at the inaugural SOSV Climate Tech Summit.
The burgeoning climate-focused portfolio from early-stage investor SOSV Investments has managed to raise nearly $2 billion in follow-on financing since the startup companies graduated from the investm
Founders in the earliest stages of startup life face a hefty learning curve. Just some of the core competencies you need to lock down include how to raise VC funding, recruiting the right people, find
There’s a growing wave of commercial activity from companies that are creating products using new biological engineering technologies. Perhaps the most public (and tastiest) example of the promi
Arvind Gupta, the founder and head of IndieBio, is leaving the accelerator whose portfolio he helped build into a $3.2 billion life sciences powerhouse, to join the venture capital fund Mayfield. The
Rising healthcare costs, an aging population, stifling regulations and the complexity of present-day technological offerings make the trillion-dollar healthcare industry ripe for disruption. Not only
In this week's newsletter: Airbnb, WeWork and Postmates prep IPOs.
Learn from top VCs at TechCrunch Disrupt.
The accelerator’s demo day has grown so big we’re now live streaming it on TechCrunch. But it was just a couple years ago that the only pure biotech accelerator launched out of SOS Venture